These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 35507150

  • 41. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.
    Kershaw DB, Sedman AB, Kelsch RC, Bunchman TE.
    Clin Transplant; 1994 Dec; 8(6):546-9. PubMed ID: 7865917
    [Abstract] [Full Text] [Related]

  • 42. Successful long-term management of recurrent focal segmental glomerulosclerosis after kidney transplantation with costimulation blockade.
    Mühlbacher T, Amann K, Mahling M, Nadalin S, Heyne N, Guthoff M.
    Clin Kidney J; 2021 Jun; 14(6):1691-1693. PubMed ID: 34084465
    [Abstract] [Full Text] [Related]

  • 43. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 44. Pioglitazone enhances proteinuria reduction in complicated pediatric nephrotic syndrome.
    Hunley TE, Hidalgo G, Ng KH, Shirai Y, Miura K, Beng HM, Wu Q, Hattori M, Smoyer WE.
    Pediatr Nephrol; 2023 Apr; 38(4):1127-1138. PubMed ID: 35969278
    [Abstract] [Full Text] [Related]

  • 45. Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange.
    Fadel FI, Bazaraa HM, Abdel Mawla MA, Salah DM.
    Ital J Pediatr; 2021 Dec 14; 47(1):236. PubMed ID: 34906202
    [Abstract] [Full Text] [Related]

  • 46. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH, Lee JH, Park GY, Lim JH, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.
    Ren Fail; 2014 May 14; 36(4):623-6. PubMed ID: 24502587
    [Abstract] [Full Text] [Related]

  • 47. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis.
    Fencl F, Vondrák K, Rosík T, Zieg J, Chadimová M, Háček J, Dušek J, Seeman T.
    Minerva Pediatr; 2016 Oct 14; 68(5):348-54. PubMed ID: 26041001
    [Abstract] [Full Text] [Related]

  • 48. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 Oct 14; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 49. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H, Morelon E, Noel LH, Mamzer-Bruneel MF, Legendre C, Peraldi MN, Kreis H.
    Transpl Int; 2005 Apr 14; 18(4):458-60. PubMed ID: 15773967
    [Abstract] [Full Text] [Related]

  • 50. Therapeutic Approach for Recurrent Focal Segmental Glomerulosclerosis in Pediatric Renal Transplant Recipients: A Single-Center Experience.
    Torres DD, Fontò G, Guastamacchia L, Santangelo L, Carbone V, Piscopo G, Spadaccino F, Ranieri E, Netti GS, Giordano M.
    Blood Purif; 2022 Apr 14; 51(10):847-856. PubMed ID: 35093944
    [Abstract] [Full Text] [Related]

  • 51. Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome.
    Sgambat K, Banks M, Moudgil A.
    Pediatr Nephrol; 2013 Nov 14; 28(11):2131-5. PubMed ID: 23793883
    [Abstract] [Full Text] [Related]

  • 52. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
    Han KH, Kim SH.
    Biomed Res Int; 2016 Nov 14; 2016():3053706. PubMed ID: 27195285
    [Abstract] [Full Text] [Related]

  • 53. Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.
    Müller-Deile J, Sarau G, Kotb AM, Jaremenko C, Rolle-Kampczyk UE, Daniel C, Kalkhof S, Christiansen SH, Schiffer M.
    Sci Rep; 2021 Feb 25; 11(1):4577. PubMed ID: 33633212
    [Abstract] [Full Text] [Related]

  • 54. Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation.
    Gonzalez E, Ettenger R, Rianthavorn P, Tsai E, Malekzadeh M.
    Pediatr Transplant; 2011 Aug 25; 15(5):495-501. PubMed ID: 21338460
    [Abstract] [Full Text] [Related]

  • 55. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
    Takeuchi K, Naito S, Kawashima N, Ishigaki N, Sano T, Kamata K, Takeuchi Y.
    Nephron; 2018 Aug 25; 138(1):71-87. PubMed ID: 28965116
    [Abstract] [Full Text] [Related]

  • 56. Successful management of post-transplant focal segmental glomerulosclerosis with therapeutic plasma exchange and rituximab.
    Koutroutsos K, Charif R, Moran L, Moss J, Cook T, Roufosse C, Pusey C, Taube D, Loucaidou M.
    Clin Exp Nephrol; 2019 May 25; 23(5):700-709. PubMed ID: 30637591
    [Abstract] [Full Text] [Related]

  • 57. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T, Morito N, Shawki HH, Sato Y, Tsukaguchi H, Hamada M, Jeon H, Yadav MK, Kuno A, Tsunakawa Y, Okada R, Ojima T, Kanai M, Asano K, Imamura Y, Koshida R, Yoh K, Usui J, Yokoi H, Kasahara M, Yoshimura A, Muratani M, Kudo T, Oishi H, Yamagata K, Takahashi S.
    Kidney Int; 2020 Aug 25; 98(2):391-403. PubMed ID: 32622525
    [Abstract] [Full Text] [Related]

  • 58. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A, Kaori S, Takei T, Nitta K.
    CEN Case Rep; 2020 Aug 25; 9(3):195-199. PubMed ID: 31997159
    [Abstract] [Full Text] [Related]

  • 59. Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation.
    Kwon HE, Kim YH, Lee SA, Lee JJ, Ko Y, Shin S, Jung JH, Sung FS, Baek CH, Kim H, Park SK, Kwon H.
    BMC Nephrol; 2023 Mar 15; 24(1):53. PubMed ID: 36922759
    [Abstract] [Full Text] [Related]

  • 60. TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.
    Bitzan M, Babayeva S, Vasudevan A, Goodyer P, Torban E.
    Pediatr Nephrol; 2012 Dec 15; 27(12):2217-26. PubMed ID: 22538781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.